Introduction {#S0001}
============

Pericardial effusion, which is a common complication after coronary artery surgery (CAS), may be the cause of significant morbidity. It occurs in about 30% of patients who undergo CAS \[[@CIT0001]\]. It is often benign and small in volume, but can lead to life-threatening events, such as cardiac tamponade \[[@CIT0002]\]. Delayed postoperative cardiac tamponade following an open-heart operation is an infrequent, but potentially serious complication. Although previous reports have dealt with the clinical features and management of this problem, an optimal approach to prevent postoperative pericardial effusion and related problems has not been clearly defined \[[@CIT0003], [@CIT0005]\].

This study aims to investigate the effects of posterior pericardiotomy (PP) on the development of pericardial effusion, tamponade, and atrial fibrillation following CAS.

Material and methods {#S0002}
====================

This prospective randomized case-controlled study was carried out on 96 patients (77 men and 19 women; age: 35-78 years; mean: 58.1 years). The patients, undergoing CAS performed by the same surgical team between March 2012 and January 2013 in Istanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Research and Training Hospital, were assigned to 3 groups. After the study had received the approval of the Institutional Review Board, informed consent was obtained from all patients. A random number table was used for simple case randomization. The treatment was carried out blinded. The treating physician did not know the groups to which individual patients had been assigned. Patients with renal failure, hyperthyroidism, emergency CAS, history of cardiac operations associated with valvular heart disease, low ejection fraction (\< 35%), and preoperative atrial fibrillation or other rhythm disorders, as well as patients who did not provide research authorization, were excluded from the study.

The study groups included patients after PP (group I, *n* = 30), a control group (group II, *n* = 33), and patients without PP who received posterior pericardial tubes (the tube was placed behind the heart and sutured to the adjacent pericardial tissue to avoid tube-induced ventricular arrhythmias) (group III, *n* = 33). Anesthetic medication, cardiopulmonary bypass, and surgical techniques were similar in all groups. Antegrade intermittent tepid blood cardioplegia was used in all patients. Systemic hypothermia (32°C) and hemodilution were applied. In group I, a 4-cm longitudinal incision was made parallel and posterior to the left phrenic nerve, extending from the left inferior pulmonary vein to the diaphragm, as described by Mulay *et al*. \[[@CIT0006]\]. In group I, the relationship between the location of the distal part of circumflex anastomosis and PP was also carefully considered. All PPs were performed under cardiopulmonary bypass after proximal anastomoses were established. Moreover, all patients underwent pleurotomy and lateral pericardiotomy (approximately 3.5-4.5 cm in size) in which the internal thoracic artery (ITA) was used for anastomosis and positioned medially to the lung, which allowed the ITA to run without kinking or twisting. The inferior part of the pericardium was left open (2 cm) in our study. A straight tube was placed in the anterior mediastinum and an angled tube was placed in the left hemithorax in all patients. The left pleural cavity was routinely opened. The same postoperative pain management protocol was provided for all patients. After a routine closure of the chest, drains were frequently milked and stripped to ensure tube patency during the intensive care unit stay. Low-intermittent suction was also applied. The chest tubes were removed on the 2^nd^ postoperative day when the drainage became serous; otherwise, they remained in use for one or more days.

Pericardial effusion was defined as the accumulation of fluid in the pericardial space determined by transthoracic echocardiography (TTE). The presence of pericardial effusion on 2-dimensional TTE was assessed using the criteria previously described by Bakhshandeh *et al*. \[[@CIT0007]\]. Two-dimensional echocardiography was performed on postoperative days 1 and 5, as well as 1 month after surgery. The maximum diastolic separation between the pericardium and epicardium was measured at the tip of the mitral valve leaflet. When the diastolic echo-free space between the left ventricular posterior wall and the pericardium was \< 10 mm, the pericardial effusion was classified as small. When the space was 10-20 mm, the effusion was classified as moderate, while for spaces \> 20 mm, the effusion was classified as severe. If the diagnosis of evident pericardial effusion (moderate or severe) was established, TTE was performed daily, and the volume of the effusion was observed closely.

We compared the groups with regard to the volume of effusion on postoperative days 1, 5, and 30. In addition, each group was evaluated separately for the progression of pericardial effusion.

Cardiac tamponade was defined by clinical signs and symptoms in addition to echocardiographic criteria. Patients with no or small pericardial effusion and an uneventful postoperative course were discharged from the hospital on postoperative day 5. Patients with moderate or severe pericardial effusion underwent daily echocardiographic examinations. Patients with moderate and severe pericardial effusion were treated with non-steroidal anti-inflammatory drugs. During hospitalization, all patients were continuously monitored with the use of a portable electrocardiogram (ECG, telemetry) to detect atrial fibrillation. Atrial fibrillation was considered to be persistent and clinically significant when it lasted for more than 5 min. Intravenous amiodarone was used to treat patients with AF.

Statistical analysis was performed with the NCSS (Number Cruncher Statistical System) 2007 Statistical Software (Utah, USA). One-way ANOVA and Tukey HSD tests were used for the statistical analysis of the groups' parameters. Subgroup analysis was performed according to the results of TTE. The differences were also analyzed using χ^2^ tests and independent t-tests where applicable. Clinical data were expressed as mean ± SD. A *p* value \< 0.05 was considered statistically significant.

Results {#S0003}
=======

The hospital mortality in the study was 2% (*n* = 2); both patients were in group II. One of these patients experienced low cardiac output during and following reoperation due to cardiac tamponade and died on postoperative day 12. The other patient had an uneventful postoperative course, but was readmitted to the hospital on postoperative day 11 due to cardiac tamponade and acute kidney failure. Pericardial drainage was performed, but the patient died of sepsis on postoperative day 45.

The groups did not differ in terms of demographic parameters, which are summarized in [Table I](#T0001){ref-type="table"}. The average total volume of drainage (mediastinal and thoracic) during the first 24 hours was similar in all groups (536.67 ± 237.873 cc, 656.97 ± 407.634 cc, and 577.27 ± 374.349 cc, respectively; *p* = 0.383) ([Table II](#T0002){ref-type="table"}). In group I, the volume of the fluid evacuated by mediastinal drainage was lower than in groups II and III, but the difference was not statistically significant ([Table II](#T0002){ref-type="table"}). Two patients in group II required reoperation due to excessive mediastinal hemorrhage and cardiac tamponade. Echocardiographic evaluation demonstrated moderate to severe posterior and lateral pericardial effusions in these patients. The remaining patients underwent resternotomy. The incidence of cardiac tamponade was higher in group II (*n* = 4, 12%), and the differences between the groups were statistically significant (*p* = 0.019). Two of the patients with pericardial tamponade were managed by subxiphoid pericardial drainage alone; 400 to 1000 mL of fluid was removed. Two patients in group III were reoperated due to excessive hemorrhage in the early postoperative period.

###### 

Demographic variables in groups

  Factors                                    Group I         Group II        Group III       *p*                                    
  ----------------------------------- ------ --------------- --------------- --------------- -------------- -------- -------------- -------
  Age                                        56.9 ± 10.13    58.91 ± 10.90   58.58 ± 7.62    0.680                                  
  Sex                                 Male   23              76.67%          29              87.88%         25       75.76%         0.392
  Female                              7      23.33%          4               12.12%          8              24.24%                  
  BMI                                        28.11 ± 5.16    27.18 ± 4.28    27.68 ± 3.47    0.695                                  
  Family history, *n*                        11              36.67%          6               18.18%         15       45.45%         0.057
  COPD, *n*                                  10              33.33%          7               21.21%         15       45.45%         0.113
  DM, *n*                                    16              53.33%          12              36.36%         20       60.61%         0.131
  HT, *n*                                    15              50.00%          18              54.55%         23       69.70%         0.246
  History of smoking, *n*                    19              63.33%          20              60.61%         22       66.67%         0.877
  EF value                                                   54 ± 10.78                      52.88 ± 9.79            52.58 ± 8.30   0.829
  Number of distal bypasses           1      2               6.67%           2               6.06%          1        3.03%          0.054
  2                                   4      13.33%          7               21.21%          5              15.15%                  
  3                                   12     40.00%          13              39.39%          15             45.45%                  
  4                                   5      16.67%          11              33.33%          11             33.33%                  
  5                                   7      23.33%          0               0.00%           1              3.03%                   
  Mortality, *n*                             0               0.00%           2               6.06%          0        0.00%          0.142
  Bleeding-related revision, *n*             0               0.00%           2               6.10%          2        6.10%          0.387
  Tamponade, *n*                             0               0.00%           4               12.10%         0        0.00%          0.019
  Postoperative pneumonia, *n*               4               13.33%          12              36.36%         10       30.30%         0.106
  Postoperative AF, *n*                      6               20.00%          11              33.33%         7        21.21%         0.392
  Postoperative CVA, *n*              1      3.33%           2               6.06%           0              0.00%    0.366          
  Postoperative kidney failure, *n*          3               10.00%          4               12.12%         3        9.09%          0.918
  Cross-clamp time, minutes                  43.47 ± 15.67   45.79 ± 21.19   43.39 ± 14.68   0.821                                  
  CPB time, minutes                          79.6 ± 26.08    86.24 ± 27.33   81.79 ± 21.35   0.560                                  
  Units of RBCs                              2.4 ± 2.03      3.82 ± 3.70     2.73 ± 3.02     0.150                                  
  Hospitalization time, days                 6.63 ± 2.71     11.56 ± 10.64   8.61 ± 5.96     0.030                                  
  EuroSCORE                                  1.48 ± 1.16     1.24 ± 0.67     1.89 ± 2.04     0.175                                  

###### 

Differential drainage volume from each chest tube

  Group   Total blood loss   *p*                Mediastinal drainage tube   Pericardial drainage tube   Total mediastinal drainage volume[\*](#TF0001){ref-type="table-fn"}   *p*     Thoracic drainage tube   *p*
  ------- ------------------ ------------------ --------------------------- --------------------------- --------------------------------------------------------------------- ------- ------------------------ -------
  I       536.67 ± 237.873   0.383              200 ± 118.722               --                          200 ± 118.722                                                         0.085   340 ± 165.258            0.711
  II      656.97 ± 407.634   287.66 ± 186.188   --                          287.66 ± 186.188            346.09 ± 215.910                                                                                       
  III     577.27 ± 374.349   133.33 ± 85.847    142.42 ± 81.606             272.73 ± 164.098            304.55 ± 259.541                                                                                       

The volume of pericardial drainage was added to the volume of mediastinal drainage for group III.

The average volume of pericardial effusion significantly decreased with time in groups I and II ([Fig. 1](#F0001){ref-type="fig"}). No regression was detected in group III. Approximately 50% of the patients had small pericardial effusion on the first postoperative day; no difference between the groups was found. Moderate pericardial effusion was detected in 8 patients (group I, *n* = 1; group II, *n* = 3; group III, *n* = 4) on the first postoperative day, in 11 patients (group II, *n* = 7; group III, *n* = 4) on the fifth postoperative day, and in 7 patients on the 30^th^ postoperative day (group II, *n* = 6; group III, *n* = 1) during the study period. Severe pericardial effusion was detected in one patient (group II, *n* = 1) on the first postoperative day, in one patient (group III, *n* = 1) on the fifth postoperative day, and in one patient (group III, *n* = 1) on the 30^th^ postoperative day. The incidence of moderate to severe pericardial effusion in group I was significantly lower than in the other groups on the 30^th^ postoperative day (*n* = 0, *p* = 0.028). [Figure 1](#F0001){ref-type="fig"} shows a comparison of the groups with regard to the volume of pericardial effusion. Seven patients underwent reoperation. Four of these patients (group II, *n* = 4) underwent drainage of severe pericardial effusion on postoperative days 0, 1, 11, and 17; one patient (group II) underwent sternal dehiscence repair. None of the patients in group I required any intervention for pericardial effusions.

![Comparison of the groups with regard to the volume of pericardial effusion](KITP-11-23067-g001){#F0001}

Atrial fibrillation was detected in 24 of the 96 patients (25%: 6 patients in group I, 11 patients in group II, 7 patients in group III). No statistically significant difference between the groups (*p* = 0.392) was present in this respect.

The length of hospital stay was significantly shorter in group I (6.63 ± 2.71, *p* = 0.03).

Discussion {#S0004}
==========

There are a number of articles favoring the use of posterior pericardiotomy, but no comprehensive comparison has been conducted between the use of a pericardial tube and PP in patients undergoing CAS. Pericardial effusion and the associated complications are common after all kinds of cardiac surgery due to postoperative bleeding or post-cardiotomy syndrome \[[@CIT0008]\]. However, clinically significant pericardial effusion occurs rarely and can be a crucial risk factor for cardiac tamponade (1%) \[[@CIT0009]\]. It is also an important cause of morbidity \[[@CIT0010], [@CIT0011]\]. Many clinical approaches have been proposed to prevent postoperative pericardial effusion/tamponade. One of those methods is PP. Posterior pericardiotomy has been reported to reduce the prevalence of pericardial effusion from 40% to 8% with a simultaneous reduction in the prevalence of SVT (supraventricular tachycardia) \[[@CIT0008]\].

Pericardial and thoracic collection is mostly drained via chest tubes. In intensive care, the semi-sitting position helps thoracic drainage in the early postoperative period by supporting the patient\'s back. Despite all the above-mentioned measures, the posterior wall of the pericardial sac forms an unprotected space that may cause pericardial effusion to develop septae. This leads to the appearance of adhesions preventing blood drainage, leading to cardiac compression. Moreover, the collection of fluid may persist due to bleeding resulting from the use of anticoagulants \[[@CIT0012]\]. In fact, anti-coagulants (low-molecular-weight heparin) were used postoperatively in our patients with atrial fibrillation. Posterior pericardial effusion can be evacuated by placing a tube in the posterior pericardial space. The placement of the pericardial tube is simple to perform, but it may have certain drawbacks. The tube may come into contact with coronary grafts during cardiac activity or movement. Tube displacement may induce arrhythmia and compression of the grafts. However, the patients included in the study (in group III as well as the other groups) did not exhibit any arrhythmias (apart from AF) or ischemic changes. This may be due to the fact that we fixed the pericardial tube to the surface of the diaphragmatic pericardium with polypropylene.

Multiple comparisons of the mediastinal cavity drainage volume showed similarities between all groups. Group I, however, had lower mediastinal drainage than the remaining groups. PP or the use of posterior tubes may lessen the volume of pericardial effusion after CAS. Moreover, patients in group I exhibited regression of pericardial effusion during 30 postoperative days. This regression was statistically significant when compared to the other groups. This proved that PP had a lasting effect on pericardial effusion, as presented by [Figure 1](#F0001){ref-type="fig"}. What stands out in our results is that pericardial effusion may occur if no intervention is performed on the posterior part of the pericardium. For this reason, we recommend PP or retrocardiac tube placement.

This technique is suggested in both CAS and valve surgery, but it is not routinely used \[[@CIT0013], [@CIT0014]\]. What is more, PP is recommended by the American College of Chest Physicians Guidelines and by some authors as a preventive technique for postoperative atrial fibrillation \[[@CIT0015], [@CIT0016]\]. Several studies have emphasized the high mortality rates associated with delayed treatment \[[@CIT0017]\]. Supraventricular tachyarrhythmias, mainly in the form of atrial fibrillation, occur in up to 40% of patients undergoing CAS \[[@CIT0004]\]. Although AF is usually benign, it can cause hemodynamic instability, prolonged hospital stay, and increased cost and, in rare cases, predispose to cerebrovascular accidents \[[@CIT0018]\]. The antiarrhythmic effect of PP may, however, be a theoretical issue \[[@CIT0019]\], as we observed similar results regarding atrial fibrillation in all the groups. In fact, the results of our study were different than expected with regard to atrial fibrillation compared to other researchers \[[@CIT0004], [@CIT0006], [@CIT0016]\]. Additionally, Asimakopoulos *et al*. also found that the prevalence of atrial fibrillation was not significantly reduced (20%) in comparison to the conventional technique (26%) \[[@CIT0021]\].

Another issue is that humans have increasingly longer life spans \[[@CIT0020]\], which may result in higher numbers of reoperations. Ellman *et al*. found that patent coronary grafts were the most commonly injured structures during reoperation (46%) \[[@CIT0022]\]. Thus, the importance of covering the aorta and grafts should be emphasized. Protecting the back side of the heart against adhesions is also important. We routinely cover the aorta and proximal anastomoses of grafts with thymic fat tissue and the anterior wall of the pericardial cavity. We also place an anterior mediastinal tube over the thymic fat tissue before closing the sternum in all patients. Behind the heart, adhesions between the inferior surface of the heart and the diaphragm can cause difficulties when dissecting the tissue layers during reoperation. Mulay *et al*. demonstrated that PP provides an effective drainage pathway from the left pleural cavity, thereby reducing the prevalence of pericardial effusion \[[@CIT0006]\]. For this reason, PP may be advantageous for reoperated patients in terms of reducing adhesions related to pericardial effusion.

Echocardiography can be useful in confirming and identifying the presence of pericardial effusion, hematoma, and tamponade \[[@CIT0023]\]. According to the results of our study, it is important to diagnose pericardial effusion at an early stage. Hemodynamic deterioration due to pericardial fluid can be divided into four stages: pericardial fluid, hemodynamic tamponade, echocardiographic tamponade, clinical tamponade \[[@CIT0023]\].

The duration of hospital stay was significantly shorter in the PP group. Echocardiographic follow-up of patients with pericardial effusion might be a factor extending the duration of hospital stay. We recommend the PP technique and routine echocardiographic monitoring during the postoperative period in patients undergoing CAS.

There is not sufficient research regarding the effects of PP on long-term results \[[@CIT0024]\]. The present study also demonstrated that patients undergoing PP required a significantly shorter hospital stay and experienced lower rates of pericardial effusion and cardiac tamponade than the other groups.

Limitations {#S0005}
===========

This research was carried out on a small set of patients (*n* = 96); therefore, there was an imbalance between men and women enrolled in this trial. Atrial fibrillation was revealed in 20-33% of patients in this series. The patients were given postoperative anti-coagulants for arrhythmias. Group II had a 2-fold elevation in the number of patients going into AF postoperatively. This could have influenced the rate of tamponade and pericardial effusion in the study.

Conclusions {#S0006}
===========

In conclusion, PP may be a useful technique in the prevention of pericardial effusion and cardiac tamponade after CAS because it is simple, safe, and effective. Furthermore, it might reduce hospital stay by preventing complications, as mentioned above.

Both PP and the use of posterior tubes are effective in the early postoperative period.

*Oral presentation at the 22* ^*nd*^ *Annual Meeting of the Asian Society for Cardiovascular and Thoracic Surgery that will be held in Istanbul on April 3-6, 2014*.
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